JP5093998B2 - 色素沈着予防又は改善剤 - Google Patents

色素沈着予防又は改善剤 Download PDF

Info

Publication number
JP5093998B2
JP5093998B2 JP2005194428A JP2005194428A JP5093998B2 JP 5093998 B2 JP5093998 B2 JP 5093998B2 JP 2005194428 A JP2005194428 A JP 2005194428A JP 2005194428 A JP2005194428 A JP 2005194428A JP 5093998 B2 JP5093998 B2 JP 5093998B2
Authority
JP
Japan
Prior art keywords
pigmentation
weight
test example
component
visual comparison
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2005194428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006206575A (ja
Inventor
史樹 原野
茂生 篠原
雅彦 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2005194428A priority Critical patent/JP5093998B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to PCT/JP2005/017363 priority patent/WO2006033343A1/ja
Priority to BRPI0515585-1A priority patent/BRPI0515585A/pt
Priority to TW094132627A priority patent/TWI359662B/zh
Priority to ES05785273T priority patent/ES2421606T3/es
Priority to EP05785273.3A priority patent/EP1806120B1/en
Priority to CN2005800318371A priority patent/CN101027032B/zh
Priority to AU2005285903A priority patent/AU2005285903B2/en
Priority to US11/663,303 priority patent/US20080260878A1/en
Priority to CA2580147A priority patent/CA2580147C/en
Priority to HK07111091.8A priority patent/HK1105859B/xx
Priority to KR1020077007652A priority patent/KR101254615B1/ko
Publication of JP2006206575A publication Critical patent/JP2006206575A/ja
Application granted granted Critical
Publication of JP5093998B2 publication Critical patent/JP5093998B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2005194428A 2004-09-22 2005-07-01 色素沈着予防又は改善剤 Expired - Lifetime JP5093998B2 (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP2005194428A JP5093998B2 (ja) 2004-09-22 2005-07-01 色素沈着予防又は改善剤
US11/663,303 US20080260878A1 (en) 2004-09-22 2005-09-21 Composition for Prevention or Alleviation of Pigmentation
TW094132627A TWI359662B (cg-RX-API-DMAC7.html) 2004-09-22 2005-09-21
ES05785273T ES2421606T3 (es) 2004-09-22 2005-09-21 Composición para la prevención o el alivio de la pigmentación
EP05785273.3A EP1806120B1 (en) 2004-09-22 2005-09-21 Composition for prevention or alleviation of pigmentation
CN2005800318371A CN101027032B (zh) 2004-09-22 2005-09-21 预防或减轻色素沉着的组合物
PCT/JP2005/017363 WO2006033343A1 (ja) 2004-09-22 2005-09-21 色素沈着予防又は改善用組成物
BRPI0515585-1A BRPI0515585A (pt) 2004-09-22 2005-09-21 composição para prevenção ou melhora de pigmentação
CA2580147A CA2580147C (en) 2004-09-22 2005-09-21 Composition for prevention or alleviation of pigmentation
HK07111091.8A HK1105859B (en) 2004-09-22 2005-09-21 Composition for prevention or alleviation of pigmentation
KR1020077007652A KR101254615B1 (ko) 2004-09-22 2005-09-21 색소 침착 예방 또는 개선용 조성물
AU2005285903A AU2005285903B2 (en) 2004-09-22 2005-09-21 Composition for prevention or alleviation of pigmentation

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2004274454 2004-09-22
JP2004274454 2004-09-22
JP2004376562 2004-12-27
JP2004376562 2004-12-27
JP2005194428A JP5093998B2 (ja) 2004-09-22 2005-07-01 色素沈着予防又は改善剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012144388A Division JP5514268B2 (ja) 2004-09-22 2012-06-27 色素沈着予防又は改善剤

Publications (2)

Publication Number Publication Date
JP2006206575A JP2006206575A (ja) 2006-08-10
JP5093998B2 true JP5093998B2 (ja) 2012-12-12

Family

ID=36090101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005194428A Expired - Lifetime JP5093998B2 (ja) 2004-09-22 2005-07-01 色素沈着予防又は改善剤

Country Status (11)

Country Link
US (1) US20080260878A1 (cg-RX-API-DMAC7.html)
EP (1) EP1806120B1 (cg-RX-API-DMAC7.html)
JP (1) JP5093998B2 (cg-RX-API-DMAC7.html)
KR (1) KR101254615B1 (cg-RX-API-DMAC7.html)
CN (1) CN101027032B (cg-RX-API-DMAC7.html)
AU (1) AU2005285903B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515585A (cg-RX-API-DMAC7.html)
CA (1) CA2580147C (cg-RX-API-DMAC7.html)
ES (1) ES2421606T3 (cg-RX-API-DMAC7.html)
TW (1) TWI359662B (cg-RX-API-DMAC7.html)
WO (1) WO2006033343A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180379A (ja) * 2004-09-22 2012-09-20 Otsuka Pharmaceut Co Ltd 色素沈着予防又は改善剤

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52792B (sr) 2004-01-22 2013-10-31 University Of Miami Topijske formulacije koenzima q10 i postupci upotrebe
JP5015620B2 (ja) * 2007-01-30 2012-08-29 株式会社クラレ 皮膚外用剤
MX2010011032A (es) 2008-04-11 2011-03-01 Cytotech Labs Llc Star Metodos y uso de induccion de apoptosis en celulas cancerigenas.
JP5263940B2 (ja) * 2008-05-29 2013-08-14 株式会社 資生堂 皮膚外用剤
SG175993A1 (en) 2009-05-11 2011-12-29 Berg Biosystems Llc Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
JP5748961B2 (ja) * 2010-03-19 2015-07-15 ポーラ化成工業株式会社 組成物
AU2011270096B2 (en) 2010-06-25 2014-06-12 Otsuka Pharmaceutical Co., Ltd. Agent for suppressing the formation of abnormal skin cells caused by exposure to light
WO2012017911A1 (ja) * 2010-08-03 2012-02-09 株式会社林原生物化学研究所 美白強化剤とその用途
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
CN102813642A (zh) * 2012-09-13 2012-12-12 中南大学湘雅二医院 一种祛斑抗皮肤衰老的复方制剂
JP6166544B2 (ja) * 2013-02-13 2017-07-19 第一三共ヘルスケア株式会社 色素沈着症の予防又は治療剤
JP2016515572A (ja) * 2013-04-04 2016-05-30 ヒュンダイ ファーム カンパニー リミテッド 皮膚透過が改善された外用剤組成物
MX380565B (es) 2013-04-08 2025-03-12 Berg Llc Terapias combinadas de coenzima q10 para el tratamiento de cáncer.
CN105705162A (zh) 2013-09-04 2016-06-22 博格有限责任公司 通过持续输注辅酶q10来治疗癌症的方法
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN110678166B (zh) * 2017-04-04 2024-01-09 抗纤溶酶科技有限责任公司 增强非手术医学治疗的方法
KR102014602B1 (ko) * 2017-10-19 2019-08-29 주식회사 삼성인터네셔널 기미 개선용 화장료 조성물
US20200375867A1 (en) * 2018-01-31 2020-12-03 Otsuka Pharmaceutical Co., Ltd. Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid
CN111840417A (zh) * 2019-04-30 2020-10-30 成都铜雀台医学美容医院有限公司 一种治疗黄褐斑的针剂、其制备方法及应用
WO2021229533A1 (en) * 2020-05-14 2021-11-18 Palani Llc A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections
US20240182511A1 (en) * 2021-04-09 2024-06-06 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
KR102726678B1 (ko) * 2022-04-20 2024-11-07 주식회사 바른바름 4-알킬레졸시놀을 포함하는 고체지질 나노입자, 이를 포함하는 화장료 조성물 및 화장품

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52148615A (en) * 1976-06-07 1977-12-10 Shiyouji Yamashita Aqueous biologically active solution
JP2928414B2 (ja) * 1991-09-20 1999-08-03 ポーラ化成工業株式会社 皮膚外用剤
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
JPH09295915A (ja) * 1996-04-26 1997-11-18 Kikkoman Corp 皮膚化粧料
JPH107541A (ja) * 1996-06-20 1998-01-13 Noevir Co Ltd 皮膚外用剤
JP3687277B2 (ja) * 1997-06-10 2005-08-24 サンスター株式会社 美白化粧料
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
WO1999055302A1 (en) * 1998-04-27 1999-11-04 Color Access, Inc. Composition and method for treatment of aging skin
US6503523B2 (en) * 1998-05-07 2003-01-07 Gs Development A.B. Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones
FR2787710B1 (fr) * 1998-12-29 2001-02-23 Clarins Composition cosmetique a effet eclaircissant pour la peau
JP2001206833A (ja) * 2000-01-25 2001-07-31 Kao Corp 化粧料
WO2002011717A1 (en) * 2000-08-07 2002-02-14 Juvenon, Inc. Cosmetics to support skin metabolism
JP2002179516A (ja) * 2000-12-13 2002-06-26 Pola Chem Ind Inc 美白用組成物
JP2002284664A (ja) * 2001-03-29 2002-10-03 Shiseido Co Ltd 美白用皮膚外用剤
WO2003032941A2 (de) * 2001-10-13 2003-04-24 Beiersdorf Ag Kosmetische und/oder dermatologische wirkstoffkombination
JP2003160461A (ja) * 2001-11-21 2003-06-03 Shiseido Co Ltd 皮膚外用剤
WO2003084485A1 (fr) * 2002-04-09 2003-10-16 Otsuka Pharmaceutical Co., Ltd. Composition de proliferation cellulaire
JP4425127B2 (ja) * 2002-05-20 2010-03-03 大塚製薬株式会社 肝斑改善用組成物及びくすみ改善用組成物
JP4129574B2 (ja) * 2002-08-06 2008-08-06 大塚製薬株式会社 老化防止剤
JP2004075645A (ja) * 2002-08-22 2004-03-11 Kanebo Ltd 化粧料
JP2004107262A (ja) * 2002-09-19 2004-04-08 Nikko Chemical Co Ltd 美白化粧料
JP2004238386A (ja) * 2002-12-11 2004-08-26 Mikimoto Pharmaceut Co Ltd 医薬品、医薬部外品および化粧品
JP2004262853A (ja) * 2003-03-03 2004-09-24 Kanebo Ltd 化粧料
JP2005120023A (ja) * 2003-10-16 2005-05-12 Shiseido Co Ltd 皮膚外用剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180379A (ja) * 2004-09-22 2012-09-20 Otsuka Pharmaceut Co Ltd 色素沈着予防又は改善剤

Also Published As

Publication number Publication date
EP1806120B1 (en) 2013-05-22
CN101027032B (zh) 2010-11-24
CA2580147C (en) 2013-01-22
BRPI0515585A (pt) 2008-07-29
EP1806120A4 (en) 2009-01-28
KR20070100226A (ko) 2007-10-10
US20080260878A1 (en) 2008-10-23
CA2580147A1 (en) 2006-03-30
EP1806120A1 (en) 2007-07-11
AU2005285903A1 (en) 2006-03-30
AU2005285903B2 (en) 2011-03-03
HK1105859A1 (en) 2008-02-29
KR101254615B1 (ko) 2013-04-15
WO2006033343A1 (ja) 2006-03-30
ES2421606T3 (es) 2013-09-04
JP2006206575A (ja) 2006-08-10
TWI359662B (cg-RX-API-DMAC7.html) 2012-03-11
CN101027032A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
JP5093998B2 (ja) 色素沈着予防又は改善剤
JP2010513289A (ja) スキンケア組成物
JP5766258B2 (ja) 色素沈着予防又は改善剤
WO2008066193A1 (en) Cosmetic composition
JP2003095915A (ja) 皮膚外用組成物
JP4152324B2 (ja) 外用組成物
JP2011132182A (ja) ユーカリ幼葉抽出物及び育毛剤
JP2008007526A (ja) 外用組成物
JP2016003231A (ja) 皮膚外用剤
JP2004352627A (ja) 皮膚外用剤
JP2004123575A (ja) 外用ゲル状組成物
JP4105103B2 (ja) 外用組成物
JP2001199873A (ja) 外用組成物
JP2020007274A (ja) ヘアケア用又は皮膚用外用剤に使用するための乳化剤及びその外用剤組成物
JP2003306410A (ja) 粉末含有油中水型乳化化粧料
JP4575868B2 (ja) しわ改善剤、不全角化抑制剤、肌荒れ防止・改善剤および毛穴縮小剤
JP2532495B2 (ja) 皮膚化粧料
JP5856761B2 (ja) 皮膚外用剤およびその製造方法
JP2004010505A (ja) 化粧料
JP2000063255A (ja) 皮膚外用剤
JP2004244319A (ja) 化粧料及び皮膚外用剤
JP2004107244A (ja) 皮脂分泌抑制キット
JPH09241142A (ja) 皮膚外用剤
JP2003277251A (ja) 新規美白化粧品。
JP2003146836A (ja) 化粧料

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120627

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120731

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120828

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120918

R150 Certificate of patent or registration of utility model

Ref document number: 5093998

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150928

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term